This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Johnson & Johnson
Drug Names(s): Flubendazole
Description: Flubendazole is a benzimidazole anti-parasitic agent with broad spectrum activity against intestinal parasites.
Flubendazole was originally discovered and developed by Janssen.
JNJ and DNDi
Janssen entered into a non-exclusive, royalty-free preclinical data sharing agreement with the Drugs for Neglected Diseases initiative (DNDi) for the preclinical research of a reformulated form of flubendazole.
Partners: Drugs for Neglected Diseases initiative
Additional information available to subscribers only: